Status:
UNKNOWN
Canadian SCAD Study
Lead Sponsor:
Cardiology Research UBC
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Spontaneous Coronary Artery Dissection
Eligibility:
All Genders
Brief Summary
SCAD (Spontaneous coronary artery dissection - tear in the arterial wall that is not related to trauma) is an under-diagnosed and poorly understood condition that mostly affects young women without co...
Detailed Description
Background: Spontaneous coronary artery dissection (SCAD) is an under-diagnosed and poorly understood condition that frequently affects young women without conventional cardiovascular (CV) risk facto...
Eligibility Criteria
Inclusion
- Patients admitted with troponin-positive ACS (NSTEMI or STEMI)
- Documented NA-SCAD on coronary angiogram (including diagnosis with OCT or IVUS)
Exclusion
- Patients with troponin-negative ACS
- Patients with typical atherosclerotic coronary artery disease in other coronary arterial segments with diameter stenosis ≥50%
Key Trial Info
Start Date :
June 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT02188069
Start Date
June 1 2014
End Date
December 1 2020
Last Update
August 10 2018
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195
2
Royal Alexandra Hospital
Edmonton, Alberta, Canada
3
University of Alberta
Edmonton, Alberta, Canada
4
St. Paul's Hospital
Vancouver, British Columbia, Canada